New England Investment & Retirement Group’s Ionis Pharmaceuticals IONS Stock Holding History

New England Investment & Retirement Group’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,719	Closed	-$230K	–	61
2015 Q4	$230K	Buy	+3,719	New	+$201K	0.12%	61
2015 Q3	–	Sell	-3,733	Closed	-$200K	–	63
2015 Q2	$200K	Sell	3,733 -17,193	-82%	-$1.09M	0.1%	55
2015 Q1	$1.33M	Sell	20,926 -3,828	-15%	-$260K	0.59%	39
2014 Q4	$1.53M	Buy	24,754 +793	+3%	+$39.1K	0.6%	40
2014 Q3	$930K	Hold	23,961	–	–	0.42%	45
2014 Q2	$743K	Buy	23,961 +1,780	+8%	+$56K	0.4%	45
2014 Q1	$958K	Buy	+22,181	New	+$1.08M	0.59%	36

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

New England Investment & Retirement Group's IONS Position: Q1 2016 in Review

New England Investment & Retirement Group sold out of Ionis Pharmaceuticals (IONS) in Q1 2016, closing a stake of 3,719 shares — an estimated $230K sold.

New England Investment & Retirement Group first reported a position in IONS in Q1 2014 and held it in 7 quarters. The position peaked at $1.53M in Q4 2014. 315 funds tracked by Wall St. Rank hold IONS as of Q1 2016.

New England Investment & Retirement Group reported no remaining Ionis Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
New England Investment & Retirement Group sold 3,719 Ionis Pharmaceuticals shares in Q1 2016, an estimated $230K.
New England Investment & Retirement Group first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 7 quarters.
New England Investment & Retirement Group's Ionis Pharmaceuticals position peaked at $1.53M in Q4 2014.
315 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2016.

Based on New England Investment & Retirement Group's 13F filing for Q1 2016, filed 14 Apr 2016.